Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 6, Issue 1
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Review
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Online download statistics by month:
Online download statistics by month: December 2019 to March 2024
Abstract
Full
Pdf
Dec 2019
3
3
1
Jan 2020
29
29
4
Feb 2020
142
142
48
Mar 2020
195
195
62
Apr 2020
238
238
50
May 2020
318
318
40
Jun 2020
119
119
33
Jul 2020
80
80
24
Aug 2020
83
83
37
Sep 2020
190
190
53
Oct 2020
375
376
99
Nov 2020
461
465
115
Dec 2020
393
393
98
Jan 2021
371
370
114
Feb 2021
524
524
92
Mar 2021
915
915
166
Apr 2021
642
643
144
May 2021
521
522
150
Jun 2021
321
321
75
Jul 2021
336
336
59
Aug 2021
394
394
80
Sep 2021
483
483
80
Oct 2021
492
492
110
Nov 2021
461
459
100
Dec 2021
416
429
98
Jan 2022
384
418
112
Feb 2022
362
381
66
Mar 2022
575
628
102
Apr 2022
455
482
97
May 2022
614
649
92
Jun 2022
390
410
74
Jul 2022
337
353
43
Aug 2022
409
417
55
Sep 2022
386
407
44
Oct 2022
362
379
70
Nov 2022
368
372
47
Dec 2022
324
325
57
Jan 2023
341
343
55
Feb 2023
338
343
76
Mar 2023
454
457
107
Apr 2023
294
296
78
May 2023
324
328
70
Jun 2023
283
287
35
Jul 2023
320
326
47
Aug 2023
322
326
49
Sep 2023
438
440
51
Oct 2023
908
911
57
Nov 2023
494
501
70
Dec 2023
534
535
85
Jan 2024
245
250
82
Feb 2024
328
331
61
Mar 2024
485
490
95
Total
19576
19904
3809
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?